<--- Back to Details
First PageDocument Content
Ethics / Coherentism / Philosophical logic / Coherence theory of truth / Testimony / Paul Thagard / Truth / Oncolytics Biotech / Coherence / Philosophy / Theories of truth / Epistemology
Date: 2006-05-05 12:23:16
Ethics
Coherentism
Philosophical logic
Coherence theory of truth
Testimony
Paul Thagard
Truth
Oncolytics Biotech
Coherence
Philosophy
Theories of truth
Epistemology

 Springer[removed]Erkenntnis[removed]:295–316 DOI[removed]s10670[removed]PAUL THAGARD

Add to Reading List

Source URL: cogsci.uwaterloo.ca

Download Document from Source Website

File Size: 269,83 KB

Share Document on Facebook

Similar Documents

A Message from Dr. Matt Coffey, Interim President and CEO of Oncolytics Biotech Dear Stakeholders and Interested Parties, It has been just over a month since taking on the role of Interim President and CEO and I wanted t

DocID: 1t2Qn - View Document

Viruses / Programmed cell death / Cell signaling / Immune system / Reolysin / Oncolytics Biotech / Ras subfamily / Oncolytic virus / Apoptosis / Biology / Medicine / Cell biology

Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer

DocID: ZLVM - View Document

Ethics / Coherentism / Philosophical logic / Coherence theory of truth / Testimony / Paul Thagard / Truth / Oncolytics Biotech / Coherence / Philosophy / Theories of truth / Epistemology

 Springer[removed]Erkenntnis[removed]:295–316 DOI[removed]s10670[removed]PAUL THAGARD

DocID: XWh3 - View Document

Gynecologic Oncology Group / Endometrial cancer / Ovarian cancer / Gynecologic oncology / Fallopian tube cancer / Society of Gynecologic Oncologists / Paclitaxel / Nicholas J. Vogelzang / Oncolytics Biotech / Medicine / Oncology / Gynaecological cancer

CURRICULUM VITAE[removed])

DocID: RLDY - View Document

Clinical trial / Ipsen / Biomarker / TroVax / Oncolytics Biotech / Medicine / Health / Prostate cancer

Active Biotech and Ipsen announce completion of recruitment of tasquinimod clinical phase III study in prostate cancer

DocID: NLRG - View Document